Symptomatic children may have pulmonary embolism and/or deep vein thrombosis at similar rates to adults, despite current literature.

Long-term oxygen therapy (LTOT) is linked to reduced exacerbations and hospitalizations in COPD, ILD, and pulmonary hypertension.

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

Suppressing REM sleep with antidepressants may increase survival in patients with amyotrophic lateral sclerosis.

The HHS said it has taken the first step toward implementing most-favored-nation pricing for prescription drugs.

The FDA has expanded the approval of the Freespira Breathing System to include the treatment of panic disorder and PTSD in ...

Measles is highly contagious among those who are unvaccinated and may have severe health consequences in children under age 5 ...

In acute respiratory distress syndrome (ARDS), inflammatory phenotypes can be classified at the bedside in real time in a ...

House Republicans' proposed $880 billion reduction in Medicaid funding is expected to leave millions uninsured and lead to hospital closures.

Women with COPD, asthma, and OSA may go undiagnosed or without proper care because their symptomatology differs from the male ...

The FDA has approved Emrelis for the treatment of adult patients with locally advanced or metastatic NSCLC with high c-Met protein overexpression.

The FDA plans to begin systematically reviewing the safety of foods and food additives already available in the US market.